Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Ketoprofen
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ketozip 200 XL capsules
1001010L0BKAAAJ
|
Ketozip | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ketpron XL 100mg capsules
1001010L0BPAAAI
|
Ketpron | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ketpron XL 200mg capsules
1001010L0BPABAJ
|
Ketpron | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Orudis 100mg capsules
1001010L0BCABAB
|
Orudis | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Orudis 100mg suppositories
1001010L0BCACAP
|
Orudis | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Orudis 50mg capsules
1001010L0BCAAAA
|
Orudis | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Oruvail 150 modified-release capsules
1001010L0BDADAL
|
Oruvail (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Oruvail IM 100mg/2ml solution for injection ampoules
1001010L0BDACAG
|
Oruvail (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Tiloket 50mg capsules
1001010L0BNACAA
|
Tiloket | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Tiloket CR 100mg capsules
1001010L0BNABAI
|
Tiloket | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Tiloket CR 200mg capsules
1001010L0BNADAJ
|
Tiloket | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Valket 200 Retard capsules
1001010L0BNAAAJ
|
Tiloket | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.